[ad_1]
New York, June 22, 2021 (Global News Agency)-Reportlinker.com announced the release of the report “2021 Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Global Market Report: COVID-19 Impact and Recovery in 2030”- https://www.reportlinker.com/p06097021/?utm_source=GNW
It will increase from USD 1 billion in 2020 to USD 2.04 billion in 2021, with a compound annual growth rate (CAGR) of -2.9%. The decline is mainly due to the COVID-19 outbreak that has led to a decline in the demand for equipment and delays in treatment. It is estimated that by 2025, the market will reach a compound annual growth rate of 7.6% to reach US$2.73 billion.
The benign prostatic hyperplasia (BPH) treatment equipment and equipment market includes the sale of benign prostatic hyperplasia (BPH) treatment equipment and equipment and related services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition in which an enlarged prostate leads to obstruction of the urethra, the tube that carries urine from the bladder.
The market is segmented into resectoscopes, radiofrequency ablation devices, urology lasers, prostate stents and implants.
The market covered by this report is broken down by product into resectoscopes, radiofrequency ablation devices, urology lasers, prostate stents, and implants; end users enter hospitals, outpatient surgery centers (ASC), clinics, and homes; by type of surgery Transurethral needle ablation (TUNA), transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP), transurethral microwave hyperthermia (TUMT), laser surgery, etc.
The regions covered by this report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.
The side effects suffered by patients after BPH surgery is one of the main constraints of the BPH equipment and equipment market. For example, most…
The full story on Benzinga.com
[ad_2]
Source link
